[
 {
  "id": "pmid:42623398",
  "code": "exclude",
  "reason": "LAKANA malaria substudy measuring only parasitaemia, parasite load and haemoglobin in infants sampled before and 14 days after one dose, so it clearly reports no mortality."
 },
 {
  "id": "pmid:42620060",
  "code": "exclude",
  "reason": "MORDOR Niger substudy estimating enteric fever seroincidence from blood spots collected at baseline and year 5, so it clearly reports no mortality."
 },
 {
  "id": "pmid:42268611",
  "code": "exclude",
  "reason": "LAKANA growth substudy whose prespecified outcomes are cross-sectional anthropometric measures only, so it clearly reports no mortality."
 },
 {
  "id": "pmid:41130195",
  "code": "exclude",
  "reason": "MORDOR Niger analysis of health post logbooks covering only clinic visits, diagnoses and antibiotic prescriptions, so it clearly reports no mortality."
 },
 {
  "id": "pmid:40824641",
  "code": "exclude",
  "reason": "MORDOR Niger ancillary analysis of malaria parasitaemia in random samples of children at annual surveys only, so it clearly reports no mortality."
 },
 {
  "id": "pmid:40527304",
  "code": "exclude",
  "reason": "CHAT substudy of malaria parasitaemia from smears in a random sample of children at one visit, so it clearly reports no mortality."
 },
 {
  "id": "pmid:40154970",
  "code": "exclude",
  "reason": "Exploratory analysis of seasonal patterns in weight-for-age from AVENIR census data that neither compares azithromycin with placebo nor analyses mortality."
 },
 {
  "id": "pmid:39929535",
  "code": "exclude",
  "reason": "MORDOR laboratory substudy of respiratory pathogens in nasopharyngeal swabs from symptomatic children, so it clearly reports no mortality."
 },
 {
  "id": "pmid:35190534",
  "code": "exclude",
  "reason": "MORDOR Niger serology substudy of antibody responses in blood specimens that cites the trial's mortality result only as background, so it clearly reports no mortality."
 },
 {
  "id": "pmid:34967883",
  "code": "exclude",
  "reason": "MORDOR Niger growth substudy whose prespecified outcomes are height and weight in a sampled cohort, so it clearly reports no mortality."
 },
 {
  "id": "pmid:32822362",
  "code": "exclude",
  "reason": "Secondary analysis evaluating seasonal malaria chemoprevention within the SMC-plus-placebo arm, whose only death outcome is malaria hospitalisation or death, so it gives no azithromycin comparison and no all-cause mortality."
 },
 {
  "id": "pmid:32342841",
  "code": "exclude",
  "reason": "MORDOR Malawi substudy of parasitaemia, gametocytaemia and anaemia in random samples at cross-sectional visits, so it clearly reports no mortality."
 },
 {
  "id": "pmid:32166877",
  "code": "exclude",
  "reason": "AZ-SMC nutrition analysis from cross-sectional anthropometric surveys that cites the trial's mortality result only as background, so it clearly reports no mortality."
 },
 {
  "id": "pmid:32067629",
  "code": "exclude",
  "reason": "MORDOR Tanzania substudy of anaemia from haemoglobin in random samples at cross-sectional surveys, so it clearly reports no mortality."
 },
 {
  "id": "pmid:32067628",
  "code": "exclude",
  "reason": "MORDOR Niger cross-sectional analysis of the association between parasitaemia and nutritional status, so it clearly reports no mortality."
 },
 {
  "id": "pmid:31796025",
  "code": "exclude",
  "reason": "Malaria serology at a single visit in a trachoma azithromycin schedule trial, so it clearly reports no mortality, and the abstract does not show that the trial measured child mortality."
 },
 {
  "id": "pmid:31443654",
  "code": "exclude",
  "reason": "MORDOR Tanzania nested cohort whose stated outcomes are only RDT positivity and clinical malaria, so it clearly reports no mortality."
 },
 {
  "id": "pmid:31237871",
  "code": "exclude",
  "reason": "MORDOR Niger ancillary trial whose outcomes are parasitaemia, parasite density, haemoglobin and adverse events, with no serious adverse events reported, so it clearly reports no mortality."
 },
 {
  "id": "pmid:31166952",
  "code": "exclude",
  "reason": "Growth secondary outcomes of the TANA II trachoma trial from anthropometry at months 12 and 36, so it clearly reports no mortality, and the abstract does not show that the trial measured child mortality."
 },
 {
  "id": "pmid:30950493",
  "code": "exclude",
  "reason": "MORDOR Tanzania cohort whose outcomes are diarrhoea, respiratory symptoms, fever and anaemia at biannual surveys, so it clearly reports no mortality."
 },
 {
  "id": "pmid:30419040",
  "code": "trial_report",
  "reason": "MORDOR infant safety substudy comparing adverse events by arm, where surveillance could record deaths and the abstract does not say whether it did, so it might report mortality."
 },
 {
  "id": "pmid:25407464",
  "code": "exclude",
  "reason": "Cross-sectional anthropometry in a Gambian trachoma azithromycin schedule trial, so it clearly reports no mortality, and the abstract does not show that the trial measured child mortality."
 },
 {
  "id": "pmid:24433194",
  "code": "exclude",
  "reason": "Spleen examinations at one follow-up in a Gambian trachoma azithromycin schedule trial, so it clearly reports no mortality, and the abstract does not show that the trial measured child mortality."
 },
 {
  "id": "ppr:PPR1290969",
  "code": "exclude",
  "reason": "Preprint of the MORDOR Niger enteric fever serology substudy, which reports only seroincidence and clearly no mortality."
 },
 {
  "id": "ppr:PPR1011226",
  "code": "exclude",
  "reason": "Preprint of the CHAT malaria parasitaemia survey in a random sample of children, so it clearly reports no mortality."
 },
 {
  "id": "ppr:PPR316443",
  "code": "exclude",
  "reason": "Preprint of the MORDOR Niger serology substudy, which mentions mortality only as earlier findings, so it clearly reports no mortality."
 }
]